AI assistant
VivoSim Labs, INC. — Director's Dealing 2014
Dec 31, 2014
35369_dirs_2014-12-31_82bab326-122e-477f-84d3-e94158191672.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORGANOVO HOLDINGS, INC. (ONVO)
CIK: 0001497253
Period of Report: 2014-12-29
Reporting Person: David Eric (Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-29 | Common Stock | S | 3700 | $7.5011 | Disposed | 697706 | Direct |
| 2014-12-30 | Common Stock | S | 16300 | $7.5609 | Disposed | 681306 | Direct |
Footnotes
F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $7.50 to $7.52. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $7.50 to $7.6250. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4: This number does not include 840,000 shares of common stock underlying outstanding options held by Mr. David; post-transaction Mr. David continues to beneficially own or have a right to acquire 1,521,306 shares of common stock.